Tang Capital Management LLC Atea Pharmaceuticals, Inc. Transaction History
Tang Capital Management LLC
- $1.33 Billion
- Q4 2024
A detailed history of Tang Capital Management LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 4,788,912 shares of AVIR stock, worth $14.8 Million. This represents 1.21% of its overall portfolio holdings.
Number of Shares
4,788,912
Previous 4,607,060
3.95%
Holding current value
$14.8 Million
Previous $15.4 Million
3.95%
% of portfolio
1.21%
Previous 1.31%
Shares
6 transactions
Others Institutions Holding AVIR
# of Institutions
111Shares Held
50.9MCall Options Held
7.6KPut Options Held
38.7K-
Black Rock Inc. New York, NY9.12MShares$28.3 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$23.6 Million15.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$14.5 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.34MShares$10.4 Million0.52% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.71 Million2.25% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $258M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...